SQ-LIP-000007 · v1.8 (archived) · View current version →
Is lipedema associated with thyroid disease?
Also asked as
- Does having lipedema increase the chance of developing thyroid disorders?
- Is there a link between lipedema and thyroid conditions?
- lipedema thyroid disease association
- Are people with lipedema more likely to have problems with their thyroid?
Across multiple countries and study designs, thyroid disease — especially hypothyroidism — appears more common in people with lipedema than in the general population, with one large Spanish study reporting roughly twice the odds. However, no well-controlled study has confirmed this link is independent of obesity and being female, and the one study that formally tested independence found no significant association after adjustment, leaving it unclear whether thyroid disease is truly tied to lipedema itself or simply to shared risk factors.
- Current answer
- Lipedema is descriptively associated with elevated rates of thyroid disease — particularly hypothyroidism and chronic autoimmune thyroiditis — but this association has NOT been…
- Knowledge state
- Emerging · Evidence confidence: low (GRADE) · Stability: Evolving
- Evidence
- 8 consistent · 0 conflicting · 1 refining / contextual
- ⚠ none indexed yet — the registry may under-detect disconfirming evidence (a known limitation)
- Evidence verification
- 11/11 sources independently verified
- Main limitation
- Whether the lipedema-thyroid association is independent or merely confounded by shared obesity and sex remains unresolved: the only multivariate test (Brazilian) did not confirm…
- Latest change
- Answer recompiled after human curation of the claim set. · v1.8
- Knowledge freshness
- 82% recent · current evidence base
- Last updated
- 2026-06-02 · v1.8
Based on currently indexed evidence, lipedema is descriptively associated with elevated rates of thyroid disease — particularly hypothyroidism and chronic autoimmune thyroiditis — but this association has NOT been confirmed as independent of confounders such as obesity. The descriptive signal is consistent across many populations and study types: a German liposuction survey (n=209) reported hypothyroidism in 35.9%; Spanish cohorts identified thyroid disorders as a common comorbidity (n=1803) and, in a separate cross-sectional study of 1001 women, a significantly elevated odds ratio versus the general female population (OR=2.21; 95% CI 1.8-2.6); an Italian cohort (n=360) reported higher-than-expected autoimmune thyroiditis; a Saudi study reported hypothyroidism in 16%; a comparative cohort found thyroid disease in 24.4% of lipedema vs 14.89% of lymphedema patients; and a weighted National Inpatient Sample of obese women found hypothyroidism more prevalent in lipedema than without (23.3% vs 19%, p<0.01). However, nearly all of these are crude, unadjusted prevalence comparisons, several relying on self-reported online questionnaires. The only study that formally tested independence — a Brazilian cross-sectional screening study — found hypothyroidism common in crude terms (19.4%) but NOT an independent factor on multivariate analysis (p=0.141), suggesting the co-occurrence may reflect confounding rather than a true independent association. All supporting studies are observational (cross-sectional or retrospective), rated very-low-to-moderate quality, with largely unknown risk of bias, no randomized or prospective controlled designs, and — except the Brazilian analysis — no adjustment for BMI, sex, or healthcare-seeking behavior. The evidence is consistent in descriptive direction but remains preliminary, and the single study testing independence did not confirm it.
A synthesis rendered from the currently indexed evidence — versioned, not a verdict.
⚙ AI consolidation: Claude Opus 4.8 · 2026-06-02 — evidence-bounded; the AI does not opine
Answer recompiled after human curation of the claim set.
Knowledge freshness = share of the 11 indexed evidence sources from the last 5 years (newest 2026, oldest 2019) . Low freshness flags an ageing evidence base — not that the answer is wrong.
Evidence over time
consistent conflicting refining / contextual Each dot is a study, placed by year and coloured by whether the linked claim supports or contradicts the answer. As the surveillance loop runs, claim revisions and new evidence will extend this timeline. The hollow ring marks the first time this topic appears in the literature.
Answer over time
Each node is a published version of the answer — open one to read the answer exactly as it stood then.
Choose a format (Vancouver default). Citing a version captures the evidence state on that date; this page shows the current version — see version history.
Consistent claims
- SCR-LIP-000020 consistent
Thyroid disorders may be more frequent in lipedema than in lymphedema, with a cross-sectional cohort reporting thyroid disease in 24.4% of lipedema vs 14.89% of lymphedema patients.
Lipedema and Hypermobility Spectrum Disorders Sharing Pathophysiology: A Cross-Sectional Observational Study — Fiengo & Sbarbati (2025) - SCR-LIP-000134 consistent
In a survey of 209 German women with lipedema who underwent liposuction, hypothyroidism was present in 35.9% of participants, a frequency described as far beyond the average prevalence in the general German population.
New Insights on Lipedema: The Enigmatic Disease of the Peripheral Fat — Bauer et al. (2019) · Disease progression and comorbidities in lipedema patients: A 10‐year retrospective analysis — Ghods et al. (2020) - SCR-LIP-000135 consistent
In a cohort of 1803 lipedema patients in Spain, thyroid disorders were reported as a common comorbidity alongside other inflammatory and connective tissue conditions.
Clinical Signs at Diagnosis and Comorbidities in a Large Cohort of Patients with Lipedema in Spain — Simarro Blasco et al. (2025) · Clinical Signs at Diagnosis and Comorbidities in a Large Cohort of Patients with Lipedema in Spain — Simarro Blasco et al. (2025) - SCR-LIP-000081 consistent
In a cohort of 360 Italian women with lipedema of the lower limbs (stages 1–3), the condition was found exclusively in women and was associated with comorbidities including vitamin D insufficiency, chronic venous disease, and dyslipidemia.
Observational Study on a Large Italian Population with Lipedema: Biochemical and Hormonal Profile, Anatomical and Clinical Evaluation, Self-Reported History — Patton et al. (2024) - SCR-LIP-000245 consistent
In a cross-sectional study of patients diagnosed with lipedema in Saudi Arabia, hypothyroidism was reported as a comorbidity in 16% of patients, though no adjusted analysis of the lipedema-thyroid association was performed.
Characteristics and Clinical Features of Patients with Lipedema in Saudi Arabia: A Cross-sectional Comprehensive Assessment — Alosaimi et al. (2024) - SCR-LIP-000394 consistent
This narrative review of lipedema comorbidities lists thyroid disorders among reported associated conditions but does not provide a quantitative or adjusted test of an independent lipedema-thyroid association.
Comorbidities in lipedema: toward a systemic perspective – a narrative review — Fiengo & Sbarbati (2026) - SCR-LIP-000395 consistent
In a cross-sectional study of 1001 Spanish women with lipedema, thyroid disease was significantly more prevalent than in the general female population (OR=2.21; 95% CI: 1.8-2.6).
Prevalence of comorbidities associated with lipedema. A comparative study with the general population — Vaquero-Ramiro et al. (2026) - SCR-LIP-000396 consistent
In a weighted National Inpatient Sample cohort of obese women, hypothyroidism was more prevalent among patients with lipedema than without (23.3% vs 19%, p<0.01), though this was an unadjusted comorbidity comparison rather than a multivariate-adjusted test.
Venous thromboembolic outcomes in patients with lymphedema and lipedema: An analysis from the National Inpatient Sample — Khalid et al. (2024)
Conflicting claims
- None indexed yet.
Refining / contextual
- SCR-LIP-000137 refines
In a Brazilian cross-sectional screening study, hypothyroidism was common in women with lipedema (crude prevalence 19.4%) but was NOT an independent factor associated with lipedema on multivariate analysis (p=0.141) — the raw co-occurrence may reflect confounding (e.g. by obesity) rather than a true independent association.
Lipedema prevalence and risk factors in Brazil — Amato et al. (2022)
Major uncertainty
Whether the lipedema-thyroid association is independent or merely confounded by shared obesity and sex remains unresolved: the only multivariate test (Brazilian) did not confirm independence, and no prospective or adjusted controlled study exists.
Version history
- SQ-LIP-000007 · v1.8 — 2026-06-02 — Answer recompiled after human curation of the claim set. · view this version
- SQ-LIP-000007 · v1.7 — 2026-06-02 — This update added a narrative review (context), a Spanish cross-sectional study reporting an elevated odds ratio (OR=2.21) versus the general population, and a National Inpatient Sample showing higher crude hypothyroidism prevalence in lipedema, strengthening the descriptive signal but adding no adjusted/independent test. · view this version
- SQ-LIP-000007 · v1.6 — 2026-06-02 — Answer recompiled after human curation of the claim set. · view this version
- SQ-LIP-000007 · v1.5 — 2026-05-31 — This update added two more descriptive cross-sectional sources (a Spanish cohort of 1,803 patients and a Saudi Arabian study reporting 16% hypothyroidism), reinforcing the consistency of the descriptive association across additional populations without adding any adjusted analysis or changing the unconfirmed-independence conclusion. · view this version
- SQ-LIP-000007 · v1.4 — 2026-05-31 — Answer recompiled after human curation of the claim set. · view this version
- SQ-LIP-000007 · v1.3 — 2026-05-31 — Answer recompiled after human curation of the claim set. · view this version
- SQ-LIP-000007 · v1.2 — 2026-05-31 — This update added cross-national comparative data from Brazilian, Polish, and Dutch cohorts showing variable but consistently notable hypothyroidism prevalence rates in lipedema patients (19.4%, 31.6%, and 11.7%, respectively), reinforcing the cross-population consistency of the association while highlighting inter-cohort variability. · view this version
- SQ-LIP-000007 · v1.1 — 2026-05-31 — This update substantially strengthened the evidence base by adding three new cohorts (n=209 German, n=1803 Spanish, n=360 Italian) that consistently report elevated thyroid disorder prevalence—including specifically chronic autoimmune thyroiditis—in lipedema patients, upgrading two claims to moderate quality and broadening the finding beyond a single comparison cohort. · snapshot not archived
- SQ-LIP-000007 · v1.0 — 2026-05-30 — founding index (9 claims) · view this version
Key references
DOI:10.3390/jcm14207195 · DOI:10.1097/prs.0000000000006280 · DOI:10.1111/dth.14534 · DOI:10.3390/biomedicines13123049 · DOI:10.20944/preprints202510.1397.v1 · DOI:10.3390/ijms25031599 · DOI:10.1590/1677-5449.202101982 · DOI:10.1097/gox.0000000000006173 · DOI:10.1007/s10238-026-02157-9 · DOI:10.1177/02683555261435120 · DOI:10.1177/1358863x231219006